Patients can be trained to self-administer the medication at home
There are four GLP-1 FDA decisions to watch in 2026 Eli Lillys injectable Mounjaro, with a new indication to reduce the risk of major adverse cardiovascular events in patients with T2DM, is expected in mid-2026
Along with GLP-1s Novos Wegovy, Saxenda and Ozempic and Lillys Mounjaro the program will offer cheaper, less-effective medications such as Currax Pharmaceuticals Contrave, which reduces food cravings, and metformin, a generic diabetes drug thats also used for weight loss
If you have already used semaglutide or tirzepatide and either plateaued or found the results insufficient, retatrutide triple-receptor mechanism offers a genuinely different pharmacological approach that may break through where single or dual agonists hit their ceiling
Knezevic, E., Nenic, K., Milanovic, V